Infineon Undervalued Former Chip Unit Qimonda by $1.88 Billion, Court Expert Says
By David Sachs
Infineon Technologies undervalued its defunct memory-chip business, Qimonda, by 1.72 billion euros ($1.88 billion) during its carve-out for a public listing, the German semiconductor company said, citing a court-appointed expert's decision in a legal dispute spanning 14 years.
Qimonda, a memory-chip company in which Infineon owned a majority stake, filed for insolvency in 2009, three years after its public listing. Insolvency administrator Michael Jaffe later sued Infineon in Munich district court, claiming that Qimonda was entitled to a reimbursement because Infineon omitted certain declarations during the carve-out.
Infineon said late Monday that the expert pegged Qimonda's foreign business at minus EUR1.045 billion and its domestic business at minus EUR72.3 million, but that the sum does not equate to a liability for Infineon.
"The submission of the opinion represents an interim step in the pending legal dispute," the company said. "The amount of potential liability of Infineon depends on other aspects."
Jaffe did not immediately respond to a request for comment.
Infineon said it is unclear when a decision by the court will be reached.
As of Sept. 30, Infineon said it has recognized EUR212 million in provisions related to the lawsuit with Qimonda.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
January 09, 2024 02:52 ET (07:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks